{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:37:38Z","timestamp":1785523058883,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001794","name":"The University of Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Opinion Statement<\/jats:title>\n                  <jats:p>Trial participation is increasingly recognised as a crucial component of optimal cancer care, yet patients with advanced cancer receiving palliative care often face significant challenges in meeting the logistical demands of traditional clinical trials. Decentralised clinical trials (DCTs), including teletrials, which conduct study activities outside a central site \u2013 frequently in participant\u2019s homes or local communities - offer a promising model to overcome these barriers. By enabling remote participation, DCTs can overcome geographical and functional barriers, making trials more accessible to this often-frail population. However, there are important concerns that warrant careful consideration. DCTs may inadvertently fragment care, expose vulnerable patients to novel medications in an isolated setting, and exacerbate digital health inequities. In our experience these challenges can be mitigated through careful trial selection, as well as the implementation of rigorous screening and support systems to ensure both patient suitability and continuity of care. Key measures include close liaison with treating oncologists and palliative care teams, 24\/7 clinical phone support, accessible IT assistance during working hours, and collaboration with local trial coordinators when available. This approach not only extends the geographical reach of clinical trial participation for patients with advanced cancer receiving palliative care, but also maintains trial rigour and patient safety.<\/jats:p>","DOI":"10.1007\/s11864-026-01404-1","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T08:37:53Z","timestamp":1785141473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Future is Local: the Role of Decentralised Clinical Trials in Patients with Advanced Cancer Receiving Palliative Care"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9629-0585","authenticated-orcid":false,"given":"Claire","family":"Stokes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-0375","authenticated-orcid":false,"given":"Phillip","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","first-page":"e645","DOI":"10.7861\/clinmed.2021-0292","volume":"21","author":"K Schwarz","year":"2021","unstructured":"Schwarz K, Parasuraman S, Singh S, et al. The unspoken benefit of participation in a clinical trial. Clin Med. 2021;21:e645\u20137.","journal-title":"Clin Med"},{"key":"1404_CR2","doi-asserted-by":"publisher","first-page":"e181235","DOI":"10.1001\/jamanetworkopen.2018.1235","volume":"1","author":"JM Unger","year":"2018","unstructured":"Unger JM, Moseley A, Symington B, et al. Geographic Distribution and Survival Outcomes for Rural Patients with Cancer Treated in Clinical Trials. JAMA Netw Open. 2018;1:e181235\u2013e.","journal-title":"JAMA Netw Open"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ajco.13249","volume":"15","author":"S Sabesan","year":"2019","unstructured":"Sabesan S, Zalcberg J, Underhill C, et al. Implementation of the Australasian Teletrial Model: Lessons from practice. Asia Pac J Clin Oncol. 2019;15:3\u201314.","journal-title":"Asia Pac J Clin Oncol"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"E596","DOI":"10.1503\/cmaj.131693","volume":"186","author":"N Fernandes","year":"2014","unstructured":"Fernandes N, Bryant D, Griffith L, et al. Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis. CMAJ. 2014;186:E596\u2013609.","journal-title":"CMAJ"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/1471-0528.14528","volume":"124","author":"SK Nijjar","year":"2017","unstructured":"Nijjar SK, D\u2019Amico MI, Wimalaweera NA, et al. Participation in clinical trials improves outcomes in women\u2019s health: a systematic review and meta-analysis. BJOG. 2017;124:863\u201371.","journal-title":"BJOG"},{"key":"1404_CR6","first-page":"MR000009","volume":"2010","author":"GE Vist","year":"2008","unstructured":"Vist GE, Bryant D, Somerville L, et al. Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev. 2008;2010:MR000009.","journal-title":"Cochrane Database Syst Rev"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1371\/journal.pmed.0030188","volume":"3","author":"CP Gross","year":"2006","unstructured":"Gross CP, Krumholz HM, Van Wye G, et al. Does random treatment assignment cause harm to research participants? PLoS Med. 2006;3:e188\u2013e.","journal-title":"PLoS Med"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0895-4356(00)00305-X","volume":"54","author":"DA Braunholtz","year":"2001","unstructured":"Braunholtz DA, Edwards SJL, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a trial effect. J Clin Epidemiol. 2001;54:217\u201324.","journal-title":"J Clin Epidemiol"},{"key":"1404_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(03)15383-4","volume":"363","author":"JM Peppercorn","year":"2004","unstructured":"Peppercorn JM, Weeks JC, Cook EF, Joffe S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet. 2004;363:263\u201370.","journal-title":"Lancet"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"15368","DOI":"10.3390\/ijerph192215368","volume":"19","author":"A Bouzalmate-Hajjaj","year":"2022","unstructured":"Bouzalmate-Hajjaj A, Mass\u00f3 Guijarro P, Khan KS, et al. Benefits of Participation in Clinical Trials: An Umbrella Review. Int J Environ Res Public Health. 2022;19:15368.","journal-title":"Int J Environ Res Public Health"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1001\/jama.2024.6281","volume":"331","author":"R Iskander","year":"2024","unstructured":"Iskander R, Moyer H, Vigneault K, et al. Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs: A Systematic Review and Meta-Analysis. JAMA. 2024;331:2105\u201313.","journal-title":"JAMA"},{"key":"1404_CR12","first-page":"1056","volume":"25","author":"L McGrath-Lone","year":"2016","unstructured":"McGrath-Lone L, Ward H, Schoenborn C, Day S. The effects of cancer research participation on patient experience: a mixed-methods analysis. Eur J Cancer Care. 2016;25:1056\u201364.","journal-title":"Eur J Cancer Care"},{"key":"1404_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/08258597211063057","volume":"37","author":"A Nagla","year":"2022","unstructured":"Nagla A, Le B, White C, et al. Attitudes of Palliative Care Practitioners Towards Enrolling Patients in Clinical Trials. J Palliat Care. 2022;37:447\u201355.","journal-title":"J Palliat Care"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00520-008-0441-1","volume":"16","author":"C White","year":"2008","unstructured":"White C, Gilshenan K, Hardy J. A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care. Support Care Cancer. 2008;16:1397\u2013405.","journal-title":"Support Care Cancer"},{"key":"1404_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1743-7563.2010.01342.x","volume":"7","author":"S Sabesan","year":"2011","unstructured":"Sabesan S, Burgher B, Buettner P, et al. Attitudes, knowledge and barriers to participation in cancer clinical trials among rural and remote patients. Asia Pac J Clin Oncol. 2011;7:27\u201333.","journal-title":"Asia Pac J Clin Oncol"},{"key":"1404_CR16","first-page":"1","volume":"42","author":"CE Guerra","year":"2022","unstructured":"Guerra CE, Fleury ME, Byatt LP, et al. Strategies to Advance Equity in Cancer Clinical Trials. Am Soc Clin Oncol Educ Book. 2022;42:1\u2013137.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"1404_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/17407745221090733","volume":"19","author":"NJ McPhee","year":"2022","unstructured":"McPhee NJ, Nightingale CE, Harris SJ, et al. Barriers and enablers to cancer clinical trial participation and initiatives to improve opportunities for rural cancer patients: A scoping review. Clin Trials. 2022;19:464\u201376.","journal-title":"Clin Trials"},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s13063-020-04613-7","volume":"21","author":"MD Witham","year":"2020","unstructured":"Witham MD, Anderson E, Carroll C, et al. Developing a roadmap to improve trial delivery for under-served groups: Results from a UK multi-stakeholder process. Trials. 2020;21:694.","journal-title":"Trials"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00520-025-09763-5","volume":"33","author":"JR Hardy","year":"2025","unstructured":"Hardy JR, Greer RM, Pelecanos AM, et al. Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol. Support Care Cancer. 2025;33:715.","journal-title":"Support Care Cancer"},{"key":"1404_CR20","unstructured":"ARCS. Common Terminology for Decentralised Trials. White Paper 2023 [cited 2025 22 March]. Available from: https:\/\/www.arcs.com.au\/public\/153\/files\/News\/DIRT%20White%20Paper%20of%20Definitions%20FINAL.pdf"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1111\/bcp.15205","volume":"88","author":"A Rogers","year":"2022","unstructured":"Rogers A, De Paoli G, Subbarayan S, et al. A systematic review of methods used to conduct decentralised clinical trials. Br J Clin Pharmacol. 2022;88:2843\u201362.","journal-title":"Br J Clin Pharmacol"},{"key":"1404_CR22","doi-asserted-by":"publisher","first-page":"1081150","DOI":"10.3389\/fpubh.2022.1081150","volume":"10","author":"C Petrini","year":"2022","unstructured":"Petrini C, Mannelli C, Riva L, et al. Decentralized clinical trials (DCTs): A few ethical considerations. Front Public Health. 2022;10:1081150.","journal-title":"Front Public Health"},{"key":"1404_CR23","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s43441-024-00658-x","volume":"59","author":"T Symons","year":"2024","unstructured":"Symons T, Woollett A, Zalcberg J, Eckstein L. Implementing decentralized clinical trials in Australia through teletrials: where to from here? Ther Innov Regul Sci. 2024;59:1199\u2013203.","journal-title":"Ther Innov Regul Sci"},{"key":"1404_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/bmj.327.7413.484","volume":"327","author":"T McAlindon","year":"2003","unstructured":"McAlindon T, Formica M, Kabbara K, et al. Conducting clinical trials over the internet: feasibility study. BMJ. 2003;327:484\u20137.","journal-title":"BMJ"},{"key":"1404_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.amjmed.2004.06.023","volume":"117","author":"T McAlindon","year":"2004","unstructured":"McAlindon T, Formica M, LaValley M, et al. Effectiveness of glucosamine for symptoms of knee osteoarthritis: Results from an internet-based randomized double-blind controlled trial. Am J Med. 2004;117:643\u20139.","journal-title":"Am J Med"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/009286150403800303","volume":"38","author":"KL Eilenberg","year":"2004","unstructured":"Eilenberg KL, Hoover AM, Rutherford ML, et al. From Informed Consent through Database Lock: An Interactive Clinical Trial Conducted Using the Internet. Drug Inform J. 2004;38:239\u201351.","journal-title":"Drug Inform J"},{"key":"1404_CR27","unstructured":"Gaurav Agrawal JX, Rachel Moss R, Raschke S, Wurzer. No place like home? Stepping up the decentralization of clinical trials: McKinsey & Company; 2021 [cited 2025 March 22]. Available from: https:\/\/www.mckinsey.com\/industries\/life-sciences\/our-insights\/no-place-like-home-stepping-up-the-decentralization-of-clinical-trials"},{"key":"1404_CR28","unstructured":"PharmaIntelligence. Research Report: The Accelerated Evolution of Clinical Trials in a Pandemic Environment: Oracle. 2020 [cited 2025 March 22]. Available from: https:\/\/www.oracle.com\/oce\/dc\/assets\/CONT2CC43C146CD14B52A0A103ABD34D70BB\/native\/oracle-report-11-17-20.pdf"},{"key":"1404_CR29","doi-asserted-by":"crossref","unstructured":"Collins IM, Burbury K, Underhill CR. Teletrials: implementation of a new paradigm for clinical trials. Med J Aust. 2020;213:263-5.e1.","DOI":"10.5694\/mja2.50741"},{"key":"1404_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/1357633X211017805","volume":"29","author":"S Sabesan","year":"2023","unstructured":"Sabesan S, Malica M, Gebbie C, et al. Implementation of the Australasian Teletrial Model: Translating ideas into action using implementation science frameworks. J Telemed Telecare. 2023;29:641\u20137.","journal-title":"J Telemed Telecare"},{"key":"1404_CR31","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1093\/eurheartj\/ehab724.3177","volume":"42","author":"K Josan","year":"2021","unstructured":"Josan K, Touros A, Petlura C, et al. Validation of a pandemic-proof, decentralized cardiovascular trial: scalable design produces rapid recruitment, high engagement and protocol adherence in DeTAP (Decentralized Trial in Afib Patients). Eur Heart J. 2021;42:3177.","journal-title":"Eur Heart J"},{"key":"1404_CR32","doi-asserted-by":"crossref","unstructured":"Ali Z, Anderson K, Chiriac A et al. High adherence and low dropout rate in a virtual clinical study of atopic dermatitis through weekly reward-based personalized genetic lifestyle reports. PloS One. 2020;15:e0235500.","DOI":"10.1371\/journal.pone.0235500"},{"key":"1404_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12961-024-01270-z","volume":"22","author":"J Graffini","year":"2024","unstructured":"Graffini J, Johnston K, Farrington A, et al. The Australian clinical trial landscape: Perceptions of rural, regional and remote health service capacity and capability. Health Res Policy Syst. 2024;22:171\u201315.","journal-title":"Health Res Policy Syst"},{"key":"1404_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s13063-021-05567-0","volume":"22","author":"S Milton","year":"2021","unstructured":"Milton S, McIntosh J, Boyd L, et al. Commentary: Pivoting during a pandemic: developing a new recruitment model for a randomised controlled trial in response to COVID-19. Trials. 2021;22:605.","journal-title":"Trials"},{"key":"1404_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5694\/mja2.51078","volume":"214","author":"A Muthusamy","year":"2021","unstructured":"Muthusamy A, Long D, Underhill CR. Improving recruitment to clinical trials for regional and rural cancer patients through a regionally based clinical trials network. Med J Aust. 2021;214:453\u2013e41.","journal-title":"Med J Aust"},{"key":"1404_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-2288-12-162","volume":"12","author":"E Mathieu","year":"2012","unstructured":"Mathieu E, Barratt A, Carter SM, Jamtvedt G. Internet trials: Participant experiences and perspectives. BMC Med Res Methodol. 2012;12:162.","journal-title":"BMC Med Res Methodol"},{"key":"1404_CR37","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1177\/1357633X20950180","volume":"28","author":"JJ Lee","year":"2022","unstructured":"Lee JJ, Burbury K, Underhill C, et al. Exploring Australian regional cancer patients\u2019 experiences of clinical trial participation via telehealth. J Telemed Telecare. 2022;28:508\u201316.","journal-title":"J Telemed Telecare"},{"key":"1404_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41746-024-01214-5","volume":"7","author":"A Valachis","year":"2024","unstructured":"Valachis A, Lindman H. Lessons learned from an unsuccessful decentralized clinical trial in Oncology. NPJ Digit Med. 2024;7:211\u20133.","journal-title":"NPJ Digit Med"},{"key":"1404_CR39","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","volume":"290","author":"CJ Pepine","year":"2003","unstructured":"Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al. A Calcium Antagonist vs a Non\u2013Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease: The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial. JAMA. 2003;290:2805\u201316.","journal-title":"JAMA"},{"key":"1404_CR40","doi-asserted-by":"crossref","unstructured":"Banks MA. In the wake of COVID-19, decentralized clinical trials move to center stage. Proc Natl Acad Sci - PNAS. 2021;118:1\u20134.","DOI":"10.1073\/pnas.2119097118"},{"key":"1404_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/ajr.12852","volume":"30","author":"A Wong Shee","year":"2022","unstructured":"Wong Shee A, Quilliam C, Corboy D, et al. What shapes research and research capacity building in rural health services? Context matters. Aust J Rural Health. 2022;30:410\u201321.","journal-title":"Aust J Rural Health"},{"key":"1404_CR42","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1016\/S2589-7500(23)00052-3","volume":"5","author":"EP Vayena","year":"2023","unstructured":"Vayena EP, Blasimme AP, Sugarman JMD. Decentralised clinical trials: ethical opportunities and challenges. Lancet Digit Health. 2023;5:e390\u20134.","journal-title":"Lancet Digit Health"},{"key":"1404_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1017\/cts.2020.30","volume":"4","author":"CE Lawrence","year":"2020","unstructured":"Lawrence CE, Dunkel L, McEver M, et al. A REDCap-based model for electronic consent (eConsent): Moving toward a more personalized consent. J Clin Transl Sci. 2020;4:345\u201353.","journal-title":"J Clin Transl Sci"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-026-01404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-026-01404-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-026-01404-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:22:25Z","timestamp":1785518545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-026-01404-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1007\/s11864-026-01404-1","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"40"}}